Analgesic Contribution of the Suprazygomatic Maxillary Nerve Block for Cleft Palate Surgery in Children
Analgesic Contribution of the Suprazygomatic Maxillary Nerve Block for Cleft Palate Surgery in Children
This is a monocentric prospective randomized simple-blind designed study evaluating the
 superiority of the suprazygomatic maxillary nerve block in analgesia after cleft palate
 surgery compared with a control group. Every two hours, nurses systematically reassess the
 patient's pain and adjust the analgesic medications. Analgesic requirement, incidence of
 respiratory complications, re-feeding time and the duration of hospitalization are evaluated.
Cleft palate is the most common congenital malformation and requires early surgery given the
 complications it generates. The surgical site involving the upper airways and the use of
 morphine are providers of respiratory complications. The suprazygomatic maxillary nerve block
 could considerably reduce the use of morphine in the postoperative period and thus the
 respiratory complications in addition to an optimal comfort for the patient. The primary
 endpoint was to evaluate morphine consumption during the first postoperative 48 hours after
 cleft palate surgery.
Inclusion Criteria:

 -  children between 5 months and 12 years old

 -  weight >5kg

 -  children undergoing cleft palate repair surgery with or without upper lip surgery

 Exclusion Criteria:

 -  inappropriate age

 -  weight <5kg

 -  abnormal blood coagulation

 -  local anesthetic contraindication (including levobupivacaine, as well as any other
 associated treatment administered in this clinical study, including opioids, general
 anesthetics such as ketamine or propofol, paracetamol or corticosteroids)

 -  local infection